EndoGastric Solutions Inc-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:EndoGastric Solutions Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8014100
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月22日
◆ページ数:22
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
EndoGastric Solutions Inc (EGS), formerly EsophyX, Inc. is a medical equipment company that manufactures and markets gastroenterology and surgical products. The company’s products include esophy-x device and serosa-fuse fasteners. Its esophy-x device is used in reconstructing the gastroesophageal valve. EGS’ products are also used to perform transoral incisionless fundoplication. The company’s serosa-fuse fasteners are deployed using EsophyX devices to facilitate esophagogastric tissue plications. Its products provide solutions for hospital stay, reduced patient discomfort, faster patient recovery and patient satisfaction programs. The company develops natural orifice surgical products and procedures to treat gastrointestinal diseases. EGS is headquartered in Redmond, Washington, the US.

EndoGastric Solutions Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
EndoGastric Solutions Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
EndoGastric Solutions Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
EndoGastric Solutions Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
EndoGastric Solutions Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
EndoGastric Solutions Inc, Medical Devices Deals, 2011 to YTD 2017 9
EndoGastric Solutions Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
EndoGastric Solutions Inc, Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
EndoGastric Solutions Raises USD50 Million in Financing Round 11
Endogastric Solutions Raises US$30 Million In Series G Venture Financing 13
Endogastric Solutions Raises US$1 Million In Venture Financing 15
Endogastric Solutions Raises US$10 Million In Venture Financing 16
EndoGastric Solutions Inc – Key Competitors 17
EndoGastric Solutions Inc – Key Employees 18
EndoGastric Solutions Inc – Locations And Subsidiaries 19
Head Office 19
Recent Developments 20
Other Significant Developments 20
Oct 26, 2017: EndoGastric Solutions Announces Expanded Medicare Reimbursement for Transoral Incisionless Fundoplication Procedure 20
Appendix 22
Methodology 22
About GlobalData 22
Contact Us 22
Disclaimer 22

List of Tables
EndoGastric Solutions Inc, Pharmaceuticals & Healthcare, Key Facts 2
EndoGastric Solutions Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
EndoGastric Solutions Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
EndoGastric Solutions Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
EndoGastric Solutions Inc, Deals By Therapy Area, 2011 to YTD 2017 8
EndoGastric Solutions Inc, Medical Devices Deals, 2011 to YTD 2017 9
EndoGastric Solutions Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
EndoGastric Solutions Raises USD50 Million in Financing Round 11
Endogastric Solutions Raises US$30 Million In Series G Venture Financing 13
Endogastric Solutions Raises US$1 Million In Venture Financing 15
Endogastric Solutions Raises US$10 Million In Venture Financing 16
EndoGastric Solutions Inc, Key Competitors 17
EndoGastric Solutions Inc, Key Employees 18

★海外企業調査レポート[EndoGastric Solutions Inc-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Mizuho Financial Group Inc
    Mizuho Financial Group Inc - Strategy, SWOT and Corporate Finance Report Summary Mizuho Financial Group Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Insightra Medical Inc-医療機器分野:企業M&A・提携分析
    Summary Insightra Medical Inc (Insightra Medical), a subsidiary of GPB Life Science Holdings LLC is a medical device company that develops disposable devices. The company offers cardiovascular and surgical solutions. Its cardiovascular solutions include Ultra 7FR IAB and modulare. The Modulare Cathe …
  • Burlington Northern Santa Fe, LLC:企業の戦略・SWOT・財務情報
    Burlington Northern Santa Fe, LLC - Strategy, SWOT and Corporate Finance Report Summary Burlington Northern Santa Fe, LLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Kyowa Hakko Kirin Co., Ltd.:企業の戦略・SWOT・財務情報
    Kyowa Hakko Kirin Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Kyowa Hakko Kirin Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Google LLC:企業の戦略的SWOT分析
    Google LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. T …
  • Immunomic Therapeutics Inc-製薬・医療分野:企業M&A・提携分析
    Summary Immunomic Therapeutics Inc (ITI) is a biotechnology company that specializes in developing vaccines based on the patented lysosomal associated membrane protein or lamp technology. The company's pipeline product portfolio drugs for allergy vaccine therapy and oncology immunotherapy. It develo …
  • Cox & Kings Limited
    Cox & Kings Limited - Strategy, SWOT and Corporate Finance Report Summary Cox & Kings Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Autotelic Inc-製薬・医療分野:企業M&A・提携分析
    Summary Autotelic Inc (Autotelic) is a therapeutic drug monitoring company that develops novel treatments using its therapeutic drug monitoring (TDM) services. The company's pipeline products includes devices to improve safety and efficacy of COX-2 inhibitors, paclitaxel nanomedicine and TGF-beta in …
  • News Corporation:企業の戦略・SWOT・財務情報
    News Corporation - Strategy, SWOT and Corporate Finance Report Summary News Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Corbion NV (CRBN):企業の財務・戦略的SWOT分析
    Corbion NV (CRBN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Pizza Inn, Inc:企業の戦略・SWOT・財務情報
    Pizza Inn, Inc - Strategy, SWOT and Corporate Finance Report Summary Pizza Inn, Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • OJSC Rosneft Oil Company:企業の戦略・SWOT・財務分析
    OJSC Rosneft Oil Company - Strategy, SWOT and Corporate Finance Report Summary OJSC Rosneft Oil Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Casio Computer Co Ltd (6952):企業の財務・戦略的SWOT分析
    Casio Computer Co Ltd (6952) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Mithra Pharmaceuticals SA (MITRA):企業の財務・戦略的SWOT分析
    Summary Mithra Pharmaceuticals SA (Mithra) is a developer and manufacturer of over the counter products and prescription drugs for women’s health and other applications. The company offers products such as estelle, donesta, tibelia, zoreline and myring, among others. Its products are used in the tre …
  • Transport for London:企業の戦略的SWOT分析
    Transport for London - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • ING Group NV:企業のM&A・事業提携・投資動向
    ING Group NV - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's ING Group NV Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, …
  • Petronas Dagangan Berhad (PETDAG):石油・ガス:M&Aディール及び事業提携情報
    Summary Petronas Dagangan Bhd (Petronas Dagangan), a subsidiary of Petroliam Nasional Berhad, is an oil and gas company that retails and markets downstream oil and gas products. The company operates through its business segments such as retail, commercial, liquefied petroleum gas and lubricants. It …
  • HPQ Silicon Resources Inc (HPQ):企業の財務・戦略的SWOT分析
    Summary HPQ Silicon Resources Inc (HPQ Silicon), formerly Uragold Bay Resources, is a mining and mineral exploration company. The company carries out the business of acquisition, exploration, production and development of silicon, gold and quartz properties, among others. It holds interests in The B …
  • Idaho Power Co:電力:M&Aディール及び事業提携情報
    Summary Idaho Power Company (Idaho Power), a subsidiary of IDACORP, Inc., is an electric utility that carries out the generation, purchase, transmission, distribution and sale of electric energy. Idaho Power is regulated by the Federal Energy Regulatory Commission (FERC), as well as state regulatory …
  • TWC Enterprises Limited:戦略・SWOT・企業財務分析
    TWC Enterprises Limited - Strategy, SWOT and Corporate Finance Report Summary TWC Enterprises Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆